KLOW Research Blend

KLOW Research Blend is a proprietary multi-peptide research formulation pairing regenerative, dermal, and anti-inflammatory research peptides in a single vial for comparative study. Every batch is HPLC-tested and ships with a batch-specific third-party Certificate of Analysis (COA) confirming identity and 99%+ purity. For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.

Research Applications

KLOW is a proprietary research blend combining complementary research peptides (in the KPV, GHK-Cu, BPC-157, and TB-500 families) in one formulation. Laboratory models use combined-peptide blends to study convergent pathways across tissue repair, dermal remodeling, and inflammatory signaling. Each batch ships with a compositional third-party COA.

Purity & Verification

Every lot is analyzed by reversed-phase HPLC and, where applicable, mass spectrometry to confirm compound identity and 99%+ purity. A batch-specific, third-party Certificate of Analysis (COA) is included in the product gallery so researchers can confirm purity and identity before use. Supplied as a lyophilized (freeze-dried) powder; store sealed, cool, dry, and protected from light, and reconstitute per standard laboratory handling. Fast, tracked shipping from within the United States.

Peptide Research & Literature

Each component of the KLOW blend has its own peer-reviewed literature base. Selected published literature includes:

• Xiao B, et al. "Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis." Molecular Therapy, 2017. PMID: 28143741
• Maquart FX, et al. "In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds." Journal of Clinical Investigation, 1993. PMID: 8227353
• Staresinic M, et al. "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocyte growth." Journal of Orthopaedic Research, 2003. PMID: 14554208
• Philp D, et al. "Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice." Wound Repair and Regeneration, 2003. PMID: 12581423

These citations are provided for research reference only and do not imply any claim about the effects of this product.

Frequently Asked Questions

What is in the KLOW blend?
KLOW is a proprietary regenerative/dermal research blend; the batch-specific COA in the gallery documents its exact composition and purity.

How is KLOW different from GLOW?
KLOW adds an anti-inflammatory research peptide component to the regenerative/dermal base; the COA details each formulation.

Is a COA provided?
Yes, a batch-specific third-party COA accompanies each vial.

Is KLOW for human use?
No. It is a research formulation for laboratory use only.

What documentation comes with each order?
Each order includes a compositional third-party Certificate of Analysis confirming identity and purity of the blend.

Are these the same compounds referenced in the published research literature?
Yes. The KPV, GHK-Cu, BPC-157, and TB-500 components in this blend are the same research compounds studied in the peer-reviewed literature cited above.

For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.